Abstract

The contractor is screening O. volvulus-derived immunomodulatory proteins for the treatment of Chron?s disease and other autoimmune diseases. Such proteins are believed to have evolved to enable the helminthic parasite to chronically infect its human host by inducing tolerance or immunomodulation to parasite antigens.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201800035C-0-0-1
Application #
9787764
Study Section
Project Start
2018-08-01
Project End
2020-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2018
Total Cost
Indirect Cost

  Institution

Name
Celdara Medical, LLC
Department
Type
DUNS #
828763263
City
Lebanon
State
NH
Country
United States
Zip Code
03766